Form 4: Bioventus Inc. Director, Michelle McMurry-Heath, Reports Stock Vesting
SEC Filing
Director Michelle McMurry-Heath reports the vesting of 386 shares of Bioventus Inc. Class A Common Stock on June 16, 2024.
Summary
- On June 18, 2024, a Form 4 filing was submitted to the SEC regarding Bioventus Inc.
- The filing reports a transaction by Michelle McMurry-Heath, a director of Bioventus Inc.
- On June 16, 2024, 386 shares of Class A Common Stock vested at a price of $0.
- These shares were obtained through the vesting of Restricted Stock Units (RSUs).
- Following the transaction, McMurry-Heath directly owns 48,205 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock vesting, which is part of standard compensation practices.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of stock for a director, which is a common form of compensation.
Stakeholder Impact
- The vesting of shares may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/16/2024 | Date of the transaction (stock vesting). |
| 06/18/2024 | Date the Form 4 was filed. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.